myclimate study reveals SkyCell containers reduce carbon footprint of pharma airfreight

Sep 12, 2018: Swiss-based non-profit organisation myclimate conducted a comprehensive “Comparative Carbon Footprint Study” to compare SkyCell Container solutions (SkyCell 2500 and 1500 containers) for the transport of pharmaceutical products in the temperature range 2-8°C with conventional passive solutions. The study reveals that SkyCell containers are almost cutting in half the CO2 emissions per air […]

myclimate study reveals SkyCell containers reduce carbon footprint of pharma airfreight
X

Sep 12, 2018: Swiss-based non-profit organisation myclimate conducted a comprehensive “Comparative Carbon Footprint Study” to compare SkyCell Container solutions (SkyCell 2500 and 1500 containers) for the transport of pharmaceutical products in the temperature range 2-8°C with conventional passive solutions.

The study reveals that SkyCell containers are almost cutting in half the CO2 emissions per air cargo shipment.

In a comprehensive life-cycle analysis, the climate protection partnership compared SkyCell 2500 and 1500 containers with a commonly used competitors’ product, analysing the CO2-footprint on typical cold chain routes as well as the emissions caused from manufacturing until decommissioning of the containers.

“It can be stated that the big SkyCell 2500 container with a high interior transport volume performs best when looking at the entire life-cycle of the product and shipment, followed by the smaller SkyCell 1500”, says Dr. Bettina Kahlert, Leader Resource Efficiency at myclimate.

All processes from manufacturing, preconditioning, to transport and end-of-life were analysed from cradle-to-grave in order to evaluate the CO2 footprint of the temperature-controlled containers holistically. The study compared the Global Warming Potential (GWP) of two SkyCell containers (SkyCell 1500, SkyCell 2500) to other commonly used solutions. All three units are designed for cold chain shipments of the pharmaceutical industry.

“We initiated the study, because it has been our goal right from the start to develop and run the most efficient and safest pharma container system worldwide. We wanted to verify this from an independent and trustworthy source like myclimate”, said Nico Ross, CTO of SkyCell.

Experts at myclimate analysed in detail not only the fuel consumption in air transport on typical routes, but also the complete life-cycle of transport containers. Using the ecoinvent database (www.ecoinvent.org), the environmental impact of transporting SkyCell containers was assessed and compared to a commonly used solution. The database allows the calculation of the exact environmental impact (energy consumption, carbon dioxide, polluting emissions) of transports. “From our analysis, we conclude that the C02 emissions can be significantly reduced with containers that are optimized for weight-volume ratio such as SkyCells”, says Dr. Bettina Kahlert, Leader Resource Efficiency at myclimate.

“We will keep improving our technology and services in order to eliminate product loss due to temperature excursions and to better protect our climate,” said Richard Ettl, CEO of SkyCell.

Read Full Article
Next Story
Share it